Few genes attract as much attention — or generate as much confusion — in the consumer genomics space as MTHFR. The MTHFR gene encodes methylenetetrahydrofolate reductase, an enzyme involved in folate metabolism. Two common variants, C677T and A1298C, reduce enzyme activity and are present in a substantial fraction of the population. Yet the clinical significance of these variants is far narrower than much of the wellness internet would suggest.
What MTHFR actually does
MTHFR converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate — a form of folate needed to convert homocysteine into methionine. When MTHFR activity is reduced, homocysteine can accumulate. Elevated homocysteine (hyperhomocysteinemia) has been associated in epidemiological studies with increased cardiovascular risk and neural tube defects in pregnancy.
The two variants
The C677T variant (rs1801133) reduces MTHFR enzyme activity by about 35% in heterozygotes and up to 70% in homozygotes. The A1298C variant (rs1801131) has a smaller effect on enzyme activity and a more modest influence on homocysteine levels. Being heterozygous for either variant is extremely common — roughly 10-15% of populations of European descent are homozygous for C677T.
What the evidence actually shows
Here is where the science diverges sharply from the wellness narrative. Multiple large meta-analyses and Mendelian randomization studies have found that MTHFR variants, while associated with modestly elevated homocysteine, do not independently predict cardiovascular disease, cancer, or most of the conditions frequently attributed to them online. The association between elevated homocysteine and cardiovascular risk appears to be confounded by other factors, and homocysteine-lowering trials using B vitamins have generally not reduced cardiovascular events.
The clearest established clinical significance of MTHFR C677T is in pregnancy: homozygous carriers may benefit from supplementation with the active form of folate (methylfolate rather than folic acid) to support adequate homocysteine metabolism. This is an area of genuine clinical relevance, particularly given that folic acid requires MTHFR activity to be converted to its active form.
What it does not mean
MTHFR variants are commonly cited online as causes of anxiety, depression, autism, chronic fatigue, fibromyalgia, and dozens of other conditions. The evidentiary basis for these claims is weak to nonexistent. Being a C677T homozygote does not mean you are “detoxing poorly,” have a “methylation block,” or need an expensive supplement protocol. The variants are common precisely because they have minimal effect on health outcomes in the context of a diet with adequate folate.
How Vogelview presents MTHFR
In a Vogelview DNA report, MTHFR variants are reported with an evidence level of Moderate for the pregnancy and homocysteine association, and findings are carefully scoped to what the literature actually supports. We deliberately avoid the over-interpretation common in the wellness space — our goal is accurate, hedged interpretation, not alarming findings that drive unnecessary supplement purchases.